Jeff Tolin uses sophisticated techniques to ensure tax efficiency for his clients and allow them to reach their business objectives. Above all else, Jeff understands that tax planning and structuring must be consistent with client businesses and goals, so he focuses on finding practical, effective solutions that align with his clients' vision.
Cooley advised RayzeBio, a targeted radiopharmaceutical company developing an innovative pipeline against solid tumor targets, on its upsized $357.6 million initial public offering.
TriSalus Life Sciences Completes Merger With MedTech Acquisition Corporation
August 16, 2023
Cooley advised TriSalus Life Sciences, an oncology company with a focus on treatments for patients with liver and pancreatic tumors, on its merger with MedTech Acquisition Corporation.
Cooley advised Sprout Social, a social media management software company, on its $140 million acquisition of Tagger Media, a top influencer marketing platform, and a concurrent $100 million secured debt facility, which will be partially used to fund the acquisition.
Travere Sells Bile Acid Product Portfolio to Mirum
July 18, 2023
Cooley advised Travere Therapeutics, a biopharmaceutical company, on its definitive agreement to sell its bile acid product portfolio to Mirum Pharmaceuticals.
